Why are COVID-19 vaccination rates still low in some countries? Limited supplies remain a problem, but experts say other challenges
Month: March 2022
WHO recommends Merck COVID pill for non-severe, at-risk patients
The World Health Organization on Wednesday recommended an anti-COVID pill be taken by sufferers who have mild symptoms but are
Introduce price cap on cigarettes to reduce smoking, new study finds
The introduction of a maximum price-cap for cigarettes sold in the UK would limit tobacco companies’ ability to fix prices
An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis
Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers
Sigma 1 receptor protein protects brain cells most impacted by glaucoma
A ubiquitous protein called sigma 1 receptor, which is known to protect cells from stress, appears key to the function
Diminished activation of specific prefrontal brain region may directly contribute to binge eating in bulimia nervosa
New research conducted by an investigator from the Icahn School of Medicine at Mount Sinai has revealed a key neural
3-D printed ankle joints help patients walk again
In a world where hip and knee replacements have become common, orthopedic surgeons remain surprisingly divided over ankle replacements. Limb
Final practice points are issued for remdesivir use in COVID-19
In a living systematic review and updated article published online March 1 in the Annals of Internal Medicine, final practice points
Mutations in SARS-CoV-2 spike protein receptor-binding domains may yield new vaccine-resistant variants
The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and
Does nerve damage contribute to ‘long-COVID’ symptoms?
During the COVID-19 pandemic, some people infected with the SARS-CoV-2 virus continue to experience “long-COVID” symptoms persisting at least three
